Reynders Mc Veigh Capital Management, LLC Crispr Therapeutics Ag Transaction History
Reynders Mc Veigh Capital Management, LLC
- $1.9 Billion
- Q4 2024
A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 97,687 shares of CRSP stock, worth $4.13 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
97,687
Previous 119,586
18.31%
Holding current value
$4.13 Million
Previous $5.62 Million
31.56%
% of portfolio
0.2%
Previous 0.3%
Shares
17 transactions
Others Institutions Holding CRSP
# of Institutions
486Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$379 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$370 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$161 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$117 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$116 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.3B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....